Results 131 to 140 of about 204,436 (364)
Prognostic impact of peak oxygen consumption in heart failure: A systematic review and meta‐analysis
Based on 64 studies, each 1 mL/kg/min increase in VO2peak significantly reduced all‐cause mortality (HR: 0.86, 95% CI 0.82–0.90) and combined outcomes of ventricular assist device, transplant and all‐cause mortality (HR: 0.84, 95% CI 0.79–0.89) in patients with heart failure, though no significant association was observed with cardiovascular mortality (
Konstantinos Prokopidis+6 more
wiley +1 more source
Cardiac Resynchronization Therapy: Who Benefits?
Background: Cardiac resynchronization therapy (CRT) has been well established in multiple large trials to improve symptoms, hospitalizations, reverse remodeling, and mortality in well-selected patients with heart failure when used in addition to optimal ...
Jason S. Chinitz+4 more
doaj +1 more source
Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy:The BRAVO Trial [PDF]
Objectives: BRAVO (British Randomized Controlled Trial of AV and VV Optimization) is a multicenter, randomized, crossover, noninferiority trial comparing echocardiographic optimization of atrioventricular (AV) and interventricular delay with a ...
Afzal Sohaib, S.M.+27 more
core +2 more sources
In this study of 406 adults admitted with acute heart failure, the overall in‐hospital mortality rate was 3.4%. Independent predictors of in‐hospital mortality included elevated neutrophil‐lymphocyte ratio, C‐reactive protein, and potassium levels, along with moderate or severe aortic regurgitation and lower diastolic blood pressure.
Umar G. Adamu+2 more
wiley +1 more source
Abstract Aims There is growing recognition of the burden and prognostic significance of WHF treated in the outpatient setting. However, there is currently a lack of prospective real‐world data in this area of HF care. This study aims to analyse the natural history of outpatient WHF.
Joseph McCambridge+6 more
wiley +1 more source
Terapêutica de Ressincronização Cardíaca e Efeito Pró-Arrítmico: um Problema que Deve Ser Lembrado [PDF]
The demonstrated benefits of cardiac resynchronization therapy (CRT) in reducing mortality and hospitalizations for heart failure, improving NYHA functional class and inducing reverse remodeling have led to its increasing use in clinical practice ...
Branco, LM+8 more
core +1 more source
This systematic review identified 24 clinical trials of medical device and surgical interventions for HFpEF, with 16 demonstrating at least safety and feasibility, but little evidence of long‐term benefit. Phenotype‐based responses suggest that certain interventions may benefit specific HFpEF subgroups, yet most trials suffered from heterogeneous ...
Kurdo Araz+5 more
wiley +1 more source
Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients. [PDF]
AIMS: Data on longer right to left ventricular activation delay (RV-LV AD) predicting clinical outcome after cardiac resynchronization therapy (CRT) by left bundle branch block (LBBB) are limited.
Gellér, László Alajos+8 more
core +1 more source
QRS Area Is a Strong Determinant of Outcome in Cardiac Resynchronization Therapy
Background: The combination of left bundle branch block (LBBB) morphology and QRS duration is currently used to select patients for cardiac resynchronization therapy (CRT). These parameters, however, have limitations.
A. V. van Stipdonk+11 more
semanticscholar +1 more source